Reuters: Regulatory News: UPDATE 1-US FDA approves Ironwood constipation drug

Reuters: Regulatory News Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals. // via fulltextrssfeed.com

UPDATE 1-US FDA approves Ironwood constipation drug Aug 30th 2012, 15:20 Thu Aug 30, 2012 11:20am EDT Aug 30 (Reuters) - The U.S. Food and Drug Administration on Thursday approved Ironwood Pharmaceuticals Inc's drug to treat chronic constipation and irritable bowel syndrome with constipation in adults. The drug, linaclotide, will be sold under the brand name Linzess and carry a boxed warning that the drug should not be used in patients 16 years of age or younger, the agency said. "No one medication works for all patients suffering from these gastrointestinal disorders," Victoria Kusiak, a deputy director at the FDA's Center or Drug Evaluation and Research, said in a statement. "With the availability of new therapies, patients and their doctors can select the most appropriate treatment for their condition."

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions